Q3 2017
Released Nov 9, 2017, before the open
10-Q filed Nov 9, 2017, 40 days after period end · 0001493152-17-012641
Q3 2017 · 10-Q
Revenue$916.00K$916.00K +92.8% vs Q3 2016+6.6% vs Q2 2017
Net Income-$632.00K-$632.00K N/M vs Q3 2016N/M vs Q2 2017
EPS Diluted-$0.01-$0.01 N/M vs Q3 2016N/M vs Q2 2017
Gross Profit$532,000+68.4%
Operating Income-$518,000N/M
Operating Cash Flowderived-$713,000N/M
Margins · derived
Gross margin58.1%−8.4 pt vs Q3 2016
Operating margin-56.6%+77.6 pt vs Q3 2016
Net margin-69.0%+79.6 pt vs Q3 2016
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Revenue | $916.00K | $475.00K | $320.00K | $491.00K |
| Net Income | -$632.00K | -$706.00K | -$581.00K | $2.72M |
| EPS Diluted | -$0.01 | -$0.01 | -$0.02 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR